FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis

International Journal of Oral and Maxillofacial Surgery

Volumn 40, Issue 4, 2011, Pages 419-426

  Nariai, Y ^a   Mishima, K ^b   Yoshimura, Y ^a   Sekine, J ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b Western Shimane Medical Center of Health and Welfare for Disability   (Japan)

Author keywords

chemoresistance; FAP 1; NF B; oral squamous cell carcinoma; p53; radioresistance

Indexed keywords

ANTINEOPLASTIC AGENT; FAS ASSOCIATED PHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUTH CARCINOMA; ORAL BIOPSY; OVERALL SURVIVAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NF-KAPPA B; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13; RADIATION TOLERANCE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79954418848     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2010.10.020     Document Type: Article

References (40)

1. M. Bennett, K. Macdonald, S.-W. Chan, J.P. Luzio, R. Simari, and P. Weissberg Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis Science 282 1998 290 293 10.1126/science.282.5387.290 (Pubitemid 28487200)
2. P. Boscolo-Rizzo, M. Stellin, R. Fuson, C. Marchiori, A. Gava, and M.C. Da Mosto Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: surgery and postoperative radiotherapy versus concurrent chemoradiation Oral Oncol 45 2009 953 957 10.1016/j.oraloncology. 2009.06.005
3. G. Bossi, and A. Sacchi Restoration of wild-type p53 function in human cancer: relevance for tumor therapy Head Neck 29 2007 272 284 10.1002/hed.20529 (Pubitemid 46339325)
4. J. Carlos de Vicente, L.M. Junquera Gutiérrez, A.H. Zapatero, M.F. Fresno Forcelledo, G. Hernández-Vallejo, and J.S. López Arranz Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases Head Neck 26 2004 22 30 10.1002/hed.10339
5. P. Celec Nuclear factor kappa B - molecular biomedicine: the next generation Biomed Pharmacother 58 2004 365 371 10.1016/j.biopha.2003.12.015 (Pubitemid 38951071)
6. C. Couture, H. Raybaud-Diogne, B. Têtu, I. Bairati, D. Murry, J. Allard, and A. Fortin p53 and Ki-67 as markers of radioresistance in head and neck carcinoma Cancer 94 2002 713 722 10.1002/cncr.10232 (Pubitemid 34132300)
7. L.R. de Oliveira, A. Ribeiro-Silva, and S. Zucoloto Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma J Oral Pathol Med 36 2007 191 197 10.1111/j.1600-0714.2007.00517.x (Pubitemid 46495983)
8. M. El-Deiry, G.F. Funk, S. Nalwa, L.H. Karnell, R.B. Smith, J.M. Buatti, H.T. Hoffman, G.H. Clamon, S.M. Graham, D.K. Trask, K.J. Dornfeld, and M. Yao Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer Arch Otolaryngol Head Neck Surg 131 2005 879 885 (Pubitemid 41464479)
9. E.D. Foehr, G. Lorente, V. Vincent, K. Nikolich, and R. Urfer FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS J Neurooncol 74 2005 241 248 10.1007/s11060-004-7202-x (Pubitemid 41444489)
10. M. Gapany, Z.P. Pavelic, S.R. Gapany, L. Pavelic, Y.G. Li, J.M. Craven, H. Jones, P. Biddinger, P.J. Stambrook, and J.L. Gluckman Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumors Cancer Detect Prev 17 1993 379 386
11. B.A. Gusterson, R. Anbazhagan, W. Warren, C. Midgely, D.P. Lane, M. O'Hare, A. Stamps, R. Carter, and H. Jayatilake Expression of p53 in premalignant and malignant squamous epithelium Oncogene 6 1991 1785 1789 (Pubitemid 21924010)
12. C. Huang, K. Huang, C. Wang, Z.D. Jiang, X.X. Li, H.P. Wang, and H.Y. Chen Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappa B in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis Oncol Rep 22 2009 89 95 10.3892/or-00000410
13. N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 66 1991 233 243 (Pubitemid 121001362)
14. S. Irie, Y. Li, H. Kanki, T. Ohyama, L.L. Deaven, S. Somlo, and T.A. Sato Identification of Two Fas-associated phosphatase-1 (FAP-1) promoters in human cancer cells DNA Seq 11 2001 519 526 (Pubitemid 32778838)
15. V.N. Ivanov, P.L. Bergami, G. Maulit, T.A. Sato, D. Sassoon, and Z. Ronai FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface Mol Cell Biol 23 2003 3623 3635 10.1128/MCB.23.10.3623-3635.2003 (Pubitemid 36539194)
16. V.N. Ivanov, Z. Ronai, and T.K. Hei Opposite role of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis J Biol Chem 281 2006 1840 1852 10.1074/jbc.M509866200
17. J.G. Izzo, U. Malhotra, T.T. Wu, J. Ensor, R. Luthra, J.H. Lee, S.G. Swisher, Z. Liao, K.S. Chao, W.N. Hittelman, B.B. Aggarwal, and J.A. Ajani Association of activated transcription factor nuclear factor κB with chemoradiation resistance and poor outcome in esophageal carcinoma J Clin Oncol 24 2006 748 754 10.1200/JCO.2005.03.8810 (Pubitemid 46622041)
18. WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma Cancer 82 1998 2159 2165 (Pubitemid 28240822)
19. S.H. Lee, M.S. Shin, W.S. Park, S.Y. Kim, H.S. Kim, J.H. Lee, S.Y. Han, H.K. Lee, J.Y. Park, R.R. Oh, J.J. Jang, J.Y. Lee, and N.J. Yoo Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues APMIS 107 1999 1101 1108 (Pubitemid 30016635)
20. Y. Li, H. Kanki, T. Hachiya, T. Ohyama, S. Irie, G. Tang, J. Mukai, and T. Sato Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells Int J Cancer 87 2000 473 479 (Pubitemid 30639804)
21. Y.M. Long, S. Ye, J. Rong, and W.R. Xie Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma World J Gastroenterol 14 2008 4739 4744 10.3748/wjg.14.4739
22. I. Meinhold-Heerlein, F. Stenner-Liewen, H. Liewen, S. Kitada, M. Krajewska, S. Krajewski, J.M. Zapata, A. Monks, D.A. Scudiero, T. Bauknecht, and J.C. Reed Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer Am J Pathol 158 2001 1335 1344 (Pubitemid 32281297)
23. K. Mishima, Y. Nariai, and Y. Yoshimura Etodolac, a selective cyclo-oxygenase-2 inhibitor, enhances carboplatin-induced apoptosis of human tongue carcinoma cells by down-regulation of FAP-1 expression Oral Oncol 41 2005 77 81 10.1016/j.oraloncology.2004.06.009 (Pubitemid 39647123)
24. H. Nakayama, T. Ikebe, M. Beppu, and K. Shirasuna High expression levels of nuclear factor κB, IκB kinase α and Akt kinase in squamous cell carcinoma of the oral cavity Cancer 92 2001 303z 3044 10.1002/cncr.10171
25. A. Narayana, A.T. Vaughan, S. Gunaratne, S. Kathuria, S.A. Walter, and S.P. Reddy Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82 1998 286 291 (Pubitemid 28060244)
26. K. Nylander, E. Dabelsteen, and P.A. Hall The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck J Oral Pathol Med 29 2000 413 425
27. N.D. Perkins Integrating cell-signalling pathways with NF-κB and IKK function Nat Rev Mol Cell Biol 8 2007 49 62 10.1038/nrm2083 (Pubitemid 46012014)
28. W. Remmele 2nd ed. Pathologie vol. 4 1997 Springer Berlin, Heidelberg, New York p. 259
29. M. Rodriguez-Pinilla, J.L. Rodriguez-Peralto, R. Hitt, J.J. Sanchez, L. Sanchez-Verde, F. Alameda, C. Ballestin, and M. Sanchez-Cespedes β-Catenin NF-κB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters Cancer Lett 230 2005 141 148 10.1016/j.canlet.2004.12.045 (Pubitemid 41506969)
30. T. Sato, S. Irie, S. Kitada, and J.C. Reed FAP-1: a protein tyrosine phosphatase that associates with Fas Science 268 1995 411 415
31. E.R. Sauter, J.A. Ridge, J. Gordon, and B.L. Eisenberg p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base Am J Surg 164 1992 651 653
32. E.R. Sauter, J.A. Ridge, S. Litwin, and C.J. Langer Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer Clin Cancer Res 1 1995 1407 1412
33. L.H. Sobin, and Ch. Wittekind TNM classification of malignant tumours 5th ed. 2002 Wiley-Liss New York pp. 19-55
34. H. Ungefroren, M.L. Kruse, A. Trauzold, S. Roeschmann, C. Roeder, A. Arlt, D. Henne-Bruns, and H. Kalthoff FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis J Cell Sci 114 2001 2735 2746 (Pubitemid 32785453)
35. P.N. Wahi, B. Cohen, U.K. Luthra, and H. Torloni Histological typing of oral and oropharyngeal tumors, international histological classification of tumors, no. 4 1971 World Health Organization Geneva pp. 15-27
36. E. Wieckowski, Y. Atarashi, J. Stanson, T. Sato, and T.L. Whiteside FAP-1-mediated activation of NF-κB induces resistance of head and neck cancer to Fas-induced apoptosis J Cell Biochem 100 2007 16 28 10.1002/jcb.20922 (Pubitemid 44958176)
37. T. Yamada, M. Maruyama, T. Fujita, K. Miyabayashi, C. Shinoda, Y. Kawagishi, T. Fujishita, R. Hayashi, T. Miwa, N. Arai, S. Matsui, E. Sugiyama, and M. Kobayashi Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation FEBS Lett 580 2006 4387 4391 10.1016/j.febslet.2006.07.003 (Pubitemid 44118255)
38. J. Yanagisawa, M. Takahashi, H. Kanki, H. Yano-Yanagisawa, T. Tazunoki, E. Sawa, T. Nishitoba, M. Kamishohara, E. Kobayashi, S. Kataoka, and T.A. Sato The molecular interaction of Fas and FAP-1: a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis J Biol Chem 272 1997 8539 8545 (Pubitemid 27147818)
39. P.L. Zhang, P.K. Pellitteri, A. Law, P.A. Gilroy, G.C. Wood, T.L. Kennedy, T.M. Blasick, M. Lun, C. Schuerch III, and R.E. Brown Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis Mod Pathol 18 2005 924 932 (Pubitemid 41059953)
40. Y. Zheng, F. Ouaaz, P. Bruzzo, V. Singh, S. Gerondakis, and A.A. Beg NF-κB RelA (p65) is essential for TNF-α-induced Fas expression but dispensable for both TCR-induced expression and activation-induced cell death J Immunol 166 2001 4949 4957 (Pubitemid 32280705)